Literature DB >> 10745006

Crystal structure of human branched-chain alpha-ketoacid dehydrogenase and the molecular basis of multienzyme complex deficiency in maple syrup urine disease.

A AEvarsson1, J L Chuang, R M Wynn, S Turley, D T Chuang, W G Hol.   

Abstract

BACKGROUND: Mutations in components of the extraordinarily large alpha-ketoacid dehydrogenase multienzyme complexes can lead to serious and often fatal disorders in humans, including maple syrup urine disease (MSUD). In order to obtain insight into the effect of mutations observed in MSUD patients, we determined the crystal structure of branched-chain alpha-ketoacid dehydrogenase (E1), the 170 kDa alpha(2)beta(2) heterotetrameric E1b component of the branched-chain alpha-ketoacid dehydrogenase multienzyme complex.
RESULTS: The 2.7 A resolution crystal structure of human E1b revealed essentially the full alpha and beta polypeptide chains of the tightly packed heterotetramer. The position of two important potassium (K(+)) ions was determined. One of these ions assists a loop that is close to the cofactor to adopt the proper conformation. The second is located in the beta subunit near the interface with the small C-terminal domain of the alpha subunit. The known MSUD mutations affect the functioning of E1b by interfering with the cofactor and K(+) sites, the packing of hydrophobic cores, and the precise arrangement of residues at or near several subunit interfaces. The Tyr-->Asn mutation at position 393-alpha occurs very frequently in the US population of Mennonites and is located in a unique extension of the human E1b alpha subunit, contacting the beta' subunit.
CONCLUSIONS: Essentially all MSUD mutations in human E1b can be explained on the basis of the structure, with the severity of the mutations for the stability and function of the protein correlating well with the severity of the disease for the patients. The suggestion is made that small molecules with high affinity for human E1b might alleviate effects of some of the milder forms of MSUD.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10745006     DOI: 10.1016/s0969-2126(00)00105-2

Source DB:  PubMed          Journal:  Structure        ISSN: 0969-2126            Impact factor:   5.006


  42 in total

1.  Thermodynamic analysis of the binding of component enzymes in the assembly of the pyruvate dehydrogenase multienzyme complex of Bacillus stearothermophilus.

Authors:  Hyo-Il Jung; Simon J Bowden; Alan Cooper; Richard N Perham
Journal:  Protein Sci       Date:  2002-05       Impact factor: 6.725

2.  Phenylbutyrate therapy for maple syrup urine disease.

Authors:  Nicola Brunetti-Pierri; Brendan Lanpher; Ayelet Erez; Elitsa A Ananieva; Mohammad Islam; Juan C Marini; Qin Sun; Chunli Yu; Madhuri Hegde; Jun Li; R Max Wynn; David T Chuang; Susan Hutson; Brendan Lee
Journal:  Hum Mol Genet       Date:  2010-11-23       Impact factor: 6.150

3.  Functional anthology of intrinsic disorder. 3. Ligands, post-translational modifications, and diseases associated with intrinsically disordered proteins.

Authors:  Hongbo Xie; Slobodan Vucetic; Lilia M Iakoucheva; Christopher J Oldfield; A Keith Dunker; Zoran Obradovic; Vladimir N Uversky
Journal:  J Proteome Res       Date:  2007-03-29       Impact factor: 4.466

4.  Inhibition and Crystal Structure of the Human DHTKD1-Thiamin Diphosphate Complex.

Authors:  João Leandro; Susmita Khamrui; Hui Wang; Chalada Suebsuwong; Natalia S Nemeria; Khoi Huynh; Moses Moustakim; Cody Secor; May Wang; Tetyana Dodatko; Brandon Stauffer; Christopher G Wilson; Chunli Yu; Michelle R Arkin; Frank Jordan; Roberto Sanchez; Robert J DeVita; Michael B Lazarus; Sander M Houten
Journal:  ACS Chem Biol       Date:  2020-07-09       Impact factor: 5.100

Review 5.  The Pancreatic β-Cell: The Perfect Redox System.

Authors:  Petr Ježek; Blanka Holendová; Martin Jabůrek; Jan Tauber; Andrea Dlasková; Lydie Plecitá-Hlavatá
Journal:  Antioxidants (Basel)       Date:  2021-01-29

6.  Molecular architecture and mechanism of an icosahedral pyruvate dehydrogenase complex: a multifunctional catalytic machine.

Authors:  Jacqueline L S Milne; Dan Shi; Peter B Rosenthal; Joshua S Sunshine; Gonzalo J Domingo; Xiongwu Wu; Bernard R Brooks; Richard N Perham; Richard Henderson; Sriram Subramaniam
Journal:  EMBO J       Date:  2002-11-01       Impact factor: 11.598

7.  Functional characterization of the novel intronic nucleotide change c.288+9C>T within the BCKDHA gene: understanding a variant presentation of maple syrup urine disease.

Authors:  Paula Fernández-Guerra; Rosa Navarrete; Kara Weisiger; Lourdes R Desviat; Seymour Packman; Magdalena Ugarte; Pilar Rodríguez-Pombo
Journal:  J Inherit Metab Dis       Date:  2010-04-30       Impact factor: 4.982

8.  Maple syrup urine disease mutation spectrum in a cohort of 40 consanguineous patients and insilico analysis of novel mutations.

Authors:  Maryam Abiri; Hassan Saei; Maryam Eghbali; Razieh Karamzadeh; Tina Shirzadeh; Zohreh Sharifi; Sirous Zeinali
Journal:  Metab Brain Dis       Date:  2019-05-22       Impact factor: 3.584

9.  Binding of pyruvate dehydrogenase to the core of the human pyruvate dehydrogenase complex.

Authors:  Lioubov G Korotchkina; Mulchand S Patel
Journal:  FEBS Lett       Date:  2008-01-17       Impact factor: 4.124

10.  Maple syrup urine disease in Cypriot families: identification of three novel mutations and biochemical characterization of the p.Thr211Met mutation in the E1alpha subunit.

Authors:  Theodoros Georgiou; Jacinta L Chuang; R Max Wynn; Goula Stylianidou; Mark Korson; David T Chuang; Anthi Drousiotou
Journal:  Genet Test Mol Biomarkers       Date:  2009-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.